N/A N=295 A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution
Refractive Ametropia
Primary: Overall Comfort Averaged Over All Follow-up Visits — 91.7; 90.7 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=12 Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation - Pilot
Tobacco Cigarette Smoking
Primary: Smoking Urge as Assessed by Survey Item — 2.59; 2.39; 2.53; 2.16 units on a scale
Phase 2 N=48 A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
Dry Eye Disease · Dry Eye Syndrome
Primary: Stage 1: Number of Participants With Adverse Events — 5; 1; 4; 2 Participants
Phase 3 N=81 A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis
Lung Diseases, Interstitial
Primary: Annual Rate of Decline in Forced Vital Capacity (FVC) Over 52 Weeks Expressed in Milliliter (mL) — -191.89; -85.32 Milliliter/year
N/A N=8 T-GENVIH-003 LTFU (Long Term Follow Up) Study
Hernia · Hernia, Ventral · Pathological Conditions, Anatomical
Primary: Number of Participants With Clinically Confirmed Recurrence — 2 Participants
N/A N=138 Adaptive Implementation Intervention for VA Suicide Risk Identification Strategy
Suicide
Primary: Change in Columbia Suicide Severity Rating Scale Screener (C-SSRS) Uptake- Phase 1 — 13.0; 11.9 change in percent adherence — p=0.18
N/A N=30 Augmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of Depression
Major Depressive Disorder
Primary: Clinician-rated Depressive Symptoms — 19.33; 19.93; 11.33; 13.93 score on a scale — p=0.34
N/A N=5 Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
Papillary Thyroid Cancer · Papillary Thyroid Microcarcinoma
Primary: Changes in Thyroid Nodule Size — 0.241361; 0.954909; 0.422121; 0.104143 mL
Phase 3 N=53 Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma
Primary: Overall Survival — 17.6; 15.5 Months — p=0.2840
Phase 3 N=20 The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis
Allergic Contact Dermatitis
Primary: Clinical Reaction — 0; 0; 12; 8 Participants
N/A N=176 Technology-Based Intervention for Reducing Sexually Transmitted Infections and Substance Use During Pregnancy
Sexually Transmitted Infection · Alcohol Use Complicating the Puerperium · Alcohol Use Complicating Pregnancy, Unspecified Trimester
Primary: Unprotected Sexual Occasions (USOs) — 27.73; 41.50; 8.68; 14.70 USOs per participant — p=0.2964
Phase 3 N=12 A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms
Psoriasis
Primary: Percentage of Participants Achieving Psoriasis Area Severity Index (PASI) 75 (Defined as at Least 75% Improvement in PASI) — 83.3; 85.7; 85.2; 92.3 percentage of…
N/A N=15 Enhanced Community-Based Asthma Monitoring Through Novel Technology
Asthma in Children
Primary: Feasibility (Retention %) — 14 Participants
Phase 1 N=25 Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
Carcinoma, Basal Cell
Primary: Determination of RP2D — 1000 mg
N/A N=44 Effect of Black Tea Extract Impregnated Gauze on Extracted Socket
Extracted Socket
Primary: Evaluation of the Effect of Black Tea Extract-Impregnated Gauze on Primary Bleeding Cessation After Molar Extraction — 17; 12; 4; 10 Participants